C4 Therapeutics
CCCC
#8178
Rank
C$0.48 B
Marketcap
C$3.72
Share price
-5.62%
Change (1 day)
6.24%
Change (1 year)

EPS for C4 Therapeutics (CCCC)

EPS in 2026 (TTM): C-$1.01

According to C4 Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.03. In 2025 the company made an earnings per share (EPS) of C-$1.94 an increase over its 2024 EPS that were of C-$2.16.

EPS history for C4 Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.01-48.16%
2025C-$1.94-9.93%
2024C-$2.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.93 87.50%๐Ÿ‡บ๐Ÿ‡ธ USA